Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00463710 · ClinicalTrials.gov registry record
Effect of Interferon Beta-1a (Avonex®) on Changes of Non-conventional MRI Measures in Patients With MS
A clinical trial, sponsored by State University of New York at Buffalo.
- Completed
- Registry status
- 150
- Enrollment target
NCT00463710: Completed study, sponsored by State University of New York at Buffalo.
NCT00463710 is a clinical trial that has completed, run by State University of New York at Buffalo. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00463710 has completed, sponsored by State University of New York at Buffalo.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
Study Summary
Phase IV open label, single-blind study, post-marketing, 1-year MRI observational study evaluating effect of Avonex® monotherapy (6.0 MIU administered i.m. each week) on the year-to-year changes in two annual measures-magnetization transfer imaging and diffusion-weighted imaging in patients with either relapsing-remitting (RR) or secondary-progressive (SP) multiple sclerosis (MS). One hundred fifty (150) patients with RR and SP MS-followed at the Jacobs Neurological Institute, University at Buffalo, Buffalo NY-who satisfy both inclusion and exclusion criteria will be included. They will be assessed at baseline and at 12 months with MRI and clinical examinations.
Interventions
- DRUG Avonex® monotherapy (6.0 MIU administered i.m. each week)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2005-06 |
| Est. Completion | 2006-09 |
What the finished NCT00463710 record still lists
NCT00463710 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Avonex® monotherapy (6.0 MIU administered i.m. each week) is the first listed.
NCT00463710 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00463710 about?
NCT00463710 is a clinical study titled "Effect of Interferon Beta-1a (Avonex®) on Changes of Non-conventional MRI Measures in Patients With MS". Phase IV open label, single-blind study, post-marketing, 1-year MRI observational study evaluating effect of Avonex® monotherapy (6.0 MIU administered i.m. each week) on the year-to-year changes in two annual measures-magnetization transfer imaging and diffusion-weighted imaging in patients with eit...
What is the current status of trial NCT00463710?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2005-06. Estimated completion is 2006-09.
What interventions are being tested in trial NCT00463710?
The interventions under investigation include: Avonex® monotherapy (6.0 MIU administered i.m. each week) (DRUG).
Who is sponsoring clinical trial NCT00463710?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia